SUMMARY -Retinol-binding protein 4 (RBP4) is an emerging risk factor for atherosclerotic disease in adults. However, to our knowledge, there are no studies examining the relationship between RBP4 and cardiovascular risk in young population. Th erefore, we aimed to estimate this potential relationship in overweight/obese adolescent girls. Seventy overweight/obese adolescent girls, mean age 17.6±1.20 years, were included. Anthropometric and biochemical parameters were measured. Cardiovascular risk score (CVRS) was calculated by adding points for each risk factor (e.g., sex, high-density lipoprotein cholesterol (HDL-c), non-HDL-c, smoking, blood pressure and fasting glycemia). According to the risk status, we divided adolescent girls into low, medium and high risk groups (-2≤ CVRS ≤1, 2≤ CVRS ≤4 and CVRS ≥5, respectively). We found signifi cantly higher RBP4 in the high risk group as compared with low risk group (p<0.001). However, multiple linear regression analysis showed waist circumference (beta=0.257, p=0.031) to be the only independent predictor of higher cardiovascular risk (adjusted R 2 =0.342, p<0.001). In conclusion, RBP4 may be associated with higher cardiovascular risk in overweight/obese adolescent girls, but this association is mediated by abdominal obesity.
Introduction
Due to the growing proportion of children and adolescents aff ected by obesity, identifying those at an increased risk of developing cardiovascular (CV) and metabolic complications later in life is of paramount importance 1 . In addition, there is a critical need for novel biomarkers to best assess, predict and treat children that are prone to develop cardiovascular disease (CVD) 2 . Epidemiological data in Montenegro from 2008 reported that 21.2% of children and adolescents aged 7-19 years were overweight or obese 3 , whereas in 2015 the prevalence of childhood overweight and obesity was 22.9% and 5.3%, respectively 4 . Obesity is characterized by changes in adipocytokines, activation of low-grade inflammation and increased production of reactive oxygen species, leading to metabolic disorders, insulin resistance (IR), and CVD 5, 6 . Retinol-binding protein (RBP4) is a recently discovered adipokine that is involved in IR development 7 .
IR was found to be accompanied by down-regulation of the insulin responsive glucose transporter-4 (GLUT4), which might be a signal for RBP4 secretion from adipocytes and development of systemic IR 8 . Moreover, RBP4 has been recently proposed as an emerging risk factor of atherosclerotic disease in adults 9, 10 . It is well established that insulin resistance and compensatory hyperinsulinemia are the main risk factors of CVD, eventually leading to plaque formation and development of atherosclerosis, through which the prominent role of RBP4 as a modulator of atherosclerosis in hyperinsulinemia may be explained 11 . To our knowledge, there are no studies examining the relationship between RBP4 and cardiovascular risk in young obese population, having in mind that the eff ect of obesity on CVD risk often tracks from childhood and adolescence, even if manifest heart disease rarely presents before adulthood 12 . Concerning the growing proportion of pediatric population aff ected by obesity in Montenegro, we aimed to examine this potential relationship in a cohort of overweight/obese, otherwise healthy adolescent girls.
Subjects and Methods

Study population
Th e study included 70 randomly selected overweight/obese adolescent girls (mean age 17.6±1.20 years) who volunteered to participate in the study. Participants were selected from several secondary schools in Podgorica and were recruited in the Primary Health Care Center on their regular check-up in the period from December 2012 to March 2013. All the participants completed a questionnaire including demographic characteristics, somatic illnesses, medication use, and lifestyle habits. Medical history and clinical examinations were carried out on the same day. In addition, all participants with fasting glucose ≥5.6 mmol/L but ≤6.9 mmol/L underwent a two-hour oral glucose tolerance test (OGTT) with 75 g anhydrous glucose dissolved in 250 mL of water in order to exclude diabetes 13 . Inclusion criteria were overweight and obese, otherwise healthy adolescent girls aged 16-19 years. Girls younger than 16 years and older than 19 years, as well as girls with diabetes mellitus or fasting glucose ≥7.0 mmol/L were excluded from the study. Th ere were no participants with 2-hour postload glucose ≥11.1 mmol/L to be excluded from the study 13 . Furthermore, girls with renal dysfunction, hepatic dysfunction, thyroid dysfunction, cardiovascular disorders, signs and symptoms of acute infl ammatory disease, history of alcohol consumption and smoking, and those using any medications were also excluded from the study. Girls were instructed not to perform any vigorous physical activity on the day before the blood was drawn. All the participants provided their written informed consent, and for those younger than 18 years the parents' written approval was obtained. Th e study protocol was approved by the Ethics Committee of the Primary Health Care Center in Podgorica and the research was carried out in compliance with the Declaration of Helsinki 14 .
Anthropometric measurements
Basic anthropometric measurements including body height (cm), body weight (kg) and waist circumference (WC, cm) were obtained in the morning. Weight was measured to the nearest 0.1 kg on a balance beam scale, with the subjects barefoot and with light clothing. Height was measured to the nearest 0.1 cm using a wall-mounted stadiometer, without shoes. WC was measured with the non-stretchable tape, over unclothed abdomen at the midpoint between the lowest rib and the iliac crest, and at the end of normal expiration. Th e tape was parallel to the fl oor and did not compress the skin. Body mass index (BMI) was calculated as weight in kilograms divided by height in square meters (kg/m 2 ). BMI z-score was also calculated. Using the World Health Organization (WHO) growth reference 5-19 years 15 , adolescent girls were categorized as overweight (+1SD < BMI z-score < +2SD) or obese (with BMI z-score ≥ +2SD). Normal-weight girls (-2SD ≤ BMI z-score ≤ +1SD) were excluded from the study. Blood pressure was measured with a sphygmomanometer. Average of three measurements taken on the right arm was recorded. All measurements were taken by the same trained evaluator.
Th e risk of CVD was estimated using modifi ed risk score for identifying young individuals with a high probability of having advanced atherosclerotic lesions, reported by McMahan et al. 16 . Cardiovascular risk score (CVRS) was calculated by adding points for each risk factor (e.g., female sex, high-density lipoprotein cholesterol (HDL-c), non-HDL-c, smoking, blood pressure and fasting glycemia), as described previously 17 . Hypertension was defi ned as systolic blood pressure (SBP) or diastolic blood pressure (DBP) ≥130/85 mm Hg, and hyperglycemia was defi ned as fasting glucose ≥5.6 mmol/L 18 .
Biochemical analyses
Blood samples were obtained between 7.00 and 9.00 a.m., after 12-to 14-hour overnight fast. Samples were left to clot for 30 minutes and then centrifuged at 3000 rpm for 10 minutes. Serum levels of glucose, total cholesterol, HDL-c, low density lipoprotein cholesterol (LDL-c), and triglycerides (TG) were measured using standardized enzymatic procedures, spectrophotometrically (Roche Cobas 400, Mannheim, Germany). Serum RBP4 levels were determined using a nephelometric assay (Behring Nephelometer Analyzer, Marburg, Germany). Insulin was measured by chemiluminescent immunometric assay (AxSYM, Abbott, Abbott Park, IL, USA). Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated: HOMA-IR = fasting glucose (mmol/L) x fasting insulin (μIU/L)/22.5 19 .
Statistical analysis
Statistical analysis was performed using SPSS statistical package (version 15.0 for Windows, SPSS, Chicago, IL, USA). Data are presented as mean ± standard deviation, median (interquartile range), or counts and percentages. Diff erences between groups were evaluated with Student's t-test for normally and Mann-Whitney test for non-normally distributed parameters, or oneway ANOVA and Kruskal-Wallis nonparametric analysis of variance where appropriate. Spearman's nonparametric correlation analysis was used to determine the relationships between CVRS and other variables. Multiple linear regression analysis (MLR) was performed to identify independent factors aff ecting CVRS and to estimate the fi nal predictors of its variability. Due to skewed distribution, log transformed HOMA-IR and triglycerides were used. In all analyses, p value of <0.05 was considered statistically signifi cant. Table 1 shows general clinical and biochemical characteristics of the study overweight/obese participants.
Results
In the current study, we aimed to test the association of cardiometabolic parameters with the risk of CVD (as estimated using the modifi ed risk score). Th erefore, we calculated this cardiovascular risk score (CVRS) for every overweight/obese adolescent girl included in the study and, regarding their risk status level, we divided them into low, medium and high risk groups (-2≤ risk score ≤1, 2≤ risk score ≤4 and risk score ≥5, respectively). We found signifi cant diff erence in several metabolic parameters independent of risk score calculation, i.e., signifi cantly higher TG (p<0.001), insulin (p=0.007) and HOMA-IR (p=0.001), as well as anthropometric parameters (e.g., BMI, BMI z-score and WC) in the high risk group as compared with the low risk group (p=0.001, p=0.002 and p<0.001, respectively). In addition, the RBP4 level was found to increase with the increasing cardiovascular risk score (p<0.001). Th ese results are shown in Table 2 . Data are presented as mean ± standard deviation or median (interquartile range); BMI = body mass index; WC = waist circumference; HOMA-IR = homeostasis model assessment of insulin resistance; TC = total cholesterol; HDL-c = high density lipoprotein cholesterol; LDL-c = low density lipoprotein cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood pressure; RBP4 = retinol-binding protein 4 Th ereafter, we performed Spearman's nonparametric correlation to examine the potential relationship between cardiovascular risk score and cardiometabolic parameters independent of risk score calculation. As shown, CVRS correlated positively with BMI z-score (p=0.002), BMI and WC (p<0.001 both), LDL-c (p=0.003), TG (p<0.001), insulin and HOMA-IR (p<0.001 both), as well as with RBP4 level (p<0.001). No signifi cant correlations of CVRS with age and total cholesterol level were observed (Table 3) .
Multiple linear regression (MLR) analysis was performed to identify which of the measured markers showed highest association with CVRS. Namely, all variables found to have a signifi cant predictive value in Spearman's nonparametric correlation (e.g., WC, HOMA-IR, TG, RBP4), were further analyzed in MLR analysis for CVRS prediction. After MLR, WC (beta=0.257; p=0.031) was the only independent predictor of high cardiovascular risk. Th ese results are shown in Table 4 . Adjusted R 2 for the best model was 0.342, which means that 34.2% of variation in CVRS could be explained with this model.
Discussion
Th e risk of CVD later in life in apparently healthy children can be assessed by clustering individual risk factors in the same individual, thus describing status with several of these risk factors being high at the same time 20 . Obesity is one of the main risk factors associated with increased CVD risk in children and adolescents 17 . In the current study, the risk of CVD was estimated using modifi ed risk score, as described previously 17 for identifying young individuals with a high probability of having advanced atherosclerotic lesions, reported by McMahan et al. 16 . We have previously reported on the relationship between cardiovascular risk score and several established CV risk factors (e.g., ALT activity, hsCRP level, TG/HDL-c ratio, and bilirubin concentrations) in the group of adolescent girls 17 . However, there is a critical need for research in order to identify more biomarkers to best assess, predict and treat children that are prone to develop CVD. To our knowledge, the relationship between CVRS and RBP4 is a novel fi nding in the current study, considering that there are no studies examining the relationship between RBP4 and cardiovascular risk in young population. However, this association is mediated by abdominal obesity as measured by WC.
Studies in adult population have shown that RBP4 is an emerging risk factor of atherosclerotic disease 9,10 . Feng et al. 21 showed that RBP4 correlated positively with carotid atherosclerosis in patients with type 2 diabetes mellitus and could be used as an early predictor of CVD. Higher circulating RBP4 concentrations were also observed in subjects with high-grade carotid stenosis, infl ammatory dilated cardiomyopathy, coronary artery disease and advanced heart failure as compared with control subjects 9 . Even though RBP4 has been proposed as an emerging cardiometabolic risk factor in adults 10, 22 , there are discrepancies regarding some of the possible metabolic roles of RBP4 in children and adolescents [23] [24] [25] [26] . During 3-year follow up, changes in RBP4 in children indicated that increases were associated with worsening IR, independently of BMI 23 . Goodman et al. 27 provided longitudinal data on the role of RBP4 in modulating IR and suggested that the change in IR in non-Hispanic black adolescents was related to RBP4 and was dependent on the initial RBP4 level.
It is well established that IR and compensatory hyperinsulinemia are the main risk factors of CVD 11 . Insulin is a highly potent cell growth factor, which can promote vascular smooth muscle cell proliferation, thus playing an important role in the development of atherosclerosis 28 . Since RBP4 is related to IR, it has been suggested to be involved in the occurrence and development of atherosclerosis and CVD 11 . On the other hand, other studies did not fi nd signifi cant diff erences in RBP4 concentrations between patients with coronary artery disease and healthy individuals 29, 30 . In addition, in a prospective six-year study in about 1000 patients with CVD, Mallat et al. 31 found the risk of CVD to have increased with increasing RBP4 level. However, after adjustment for confounding factors, positive correlation between the RBP4 level and the risk of CVD disappeared, thus suggesting that RBP4 may not be a good predictor of CVD. In our study, RBP4 level increased in parallel with increasing cardiovascular risk score. However, our results suggest that the association between RBP4 and cardiovascular risk is not independent but that abdominal obesity may be the underlying determinant of this relationship. Our results are in line with previous studies, which suggest that RBP4 is primarily associated with adipose tissue mass 7 .
Limitations of the present study must be considered. Due to its cross-sectional design, the causal relationship between biochemical and anthropometric parameters and cardiovascular risk could not be established. It should also be noted that the small number of participants was a limitation for a study dealing with cardiovascular risk assessment. However, the fi ndings of the present study supported the hypothesis that higher serum RBP4 could in part refl ect a higher cardiovascular risk even in young overweight/obese population.
Conclusion
High serum RBP4 levels were associated with higher cardiovascular risk in overweight/obese adolescent girls, but this association was dependent on abdominal obesity, as measured by WC. Prospective studies and further analyses are needed to clarify the potential role of RBP4 in adverse cardiovascular outcomes. Better understanding of its role in CVD risk prediction in the adolescent population may lead to discovery of a new target therapy for young individuals at highest risk of malignant sequels of obesity later in life.
